How Long Does 5-Amino-1MQ Take to Work? What the Studies Measured and When

The product this page covers:

Every price is all-in, covering medication, physician review, refill management and shipping, with no membership fee. 5-Amino-1MQ is a small molecule, not a peptide, supplied as a compounded prescription injection. Compounded medications are not FDA approved.

Every study below is in cells or mice, almost all from one research group. The durations are the lengths of the experiments.

The only human data concerns the target, not the compound: a 2015 study in Diabetologia measured the enzyme NNMT in fat tissue from 199 people having abdominal surgery and found it roughly twofold higher in type 2 diabetes. Nobody in that study received 5-Amino-1MQ, so it has no timing information.

Fast measurements and slow ones

The cell findings, higher NAD+ and SAM and less fat-building, are chemical measurements taken in a dish. They are the fastest things in the literature and the furthest from anything a person would notice. The mouse body-weight, glucose and liver findings were read at the end of treatment periods of weeks. The muscle findings were in old mice over about two months. None of these was measured in a human, and none was measured at the dose in a Pepti vial.

So "28 days" is the length of the most relevant mouse experiment, which happens to be about the span of one vial. It is not a prediction of when a person on 5-Amino-1MQ would see or feel a change, and nobody can say whether a person would.

At the typical printed direction, 0.25 mL (25 units) once daily Monday through Friday:

Your physician sets your directions after reviewing your intake, and they are printed on the vial. The full unit arithmetic is in 5-Amino-1MQ dosage. A vial lasting four weeks is a supply schedule, not a results schedule.

Physicians have prescribed compounded 5-Amino-1MQ for several years, and they describe it as an adjunct to diet and activity, not a replacement, partly because the 2022 mouse study paired it with a diet change. These are uncontrolled observations, not trial endpoints, and they carry no reliable timing. The honest framing is "described in mouse and cell research and used clinically," not "shown to work in people."

What to track, if anything

Because nobody can tell you when to expect a change, a plan agreed with your physician is more useful than a date:

• Note what you are hoping to change and how you will measure it, such as waist measurement or how your clothes fit, alongside the diet and activity plan you are following.
• Keep your diet and activity steady enough that you can tell what changed.
• Report side effects as they happen rather than at the end of a vial.
• Raise it at refill if you are unsure whether to continue. A refill conversation is the right point to review, not a fixed number of weeks.

Never change your own dose, and never add doses to make something happen faster.

If you want a medication with human trial data that measured outcomes at stated weeks, 5-Amino-1MQ is not it. Semaglutide and tirzepatide have large randomized human trials with endpoints at fixed weeks; see how long do peptides take to work for how those timelines were measured. MOTS-c has observational human data, and SLU-PP-332 has none; the three are compared in MOTS-c vs SLU-PP-332 vs 5-Amino-1MQ.

There is no human safety database and no established interaction list, so list every medication and supplement on your intake, especially anything that lowers blood sugar. 5-Amino-1MQ is not used in pregnancy or breastfeeding. The full list is in 5-Amino-1MQ side effects.

What is established: a consistent cell and mouse story about blocking the enzyme NNMT, with experiments lasting from a laboratory measurement up to about two months, and one human observation about the enzyme itself.

What is not established: that 5-Amino-1MQ does anything in a person, how large any effect would be, or when it would appear. No human study has measured a timeline, an effect size or long-term safety. 5-Amino-1MQ is not an FDA-approved drug, not on the 503A bulks list, and not in Category 1, 2 or 3 of the FDA's nominated-substances list as updated 14 May 2026. It remains a compounded, prescription-only medication.

5-Amino-1MQ cannot be bought legitimately without a prescription. Sites selling it "for research use only" are not accountable for identity, purity, sterility or concentration. The prescription route:

1. Complete a free online intake covering your history, medications and what you want help with.
2. A physician licensed in your state reviews it, usually within 24 hours.
3. If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
4. It ships refrigerated with ice packs, with sterile syringes and alcohol prep pads, and your directions printed on the vial.
5. Your physician stays reachable for questions and side effects.

Pepti is cash-pay and does not bill insurance. The step-by-step page is how to get 5-Amino-1MQ prescribed online. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.